Home > News > Abraxis payout likely fuel for Soon-Shiong philanthropy
July 5th, 2010
Abraxis payout likely fuel for Soon-Shiong philanthropy
Abstract:
With last week's announcement that Patrick Soon-Shiong is selling Abraxis BioScience Inc. for $2.9 billion, the biotech entrepreneur won't have a company to run for the first time in more than two decades.
But there's one thing the billionaire will have: more money, more liquidity and more time to pursue his philanthropy, as well as possible side ventures.
Meanwhile, Soon-Shiong made it clear he is not abandoning all his business interests.
He was the inventor of the nanotechnology that has made Abraxis a success in treating late-stage breast cancer. His agreement with Celgene gives him a consulting role in the attempt to expand Abraxane's market to other cancers, including of the skin, lung and pancreas.
Source:
labusinessjournal.com
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||